v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Revenues $ 6,543,001 $ 5,065
Cost of revenues (11,071) (4,052)
Gross Profit 6,531,930 1,013
Operating expenses:    
Research and development 1,257,948 1,478,711
General and administrative 1,833,277 2,227,597
Legal expenses, net 6,850 (1,739,493)
Indirect tax expense 198,146
Total operating expenses 3,296,221 1,966,815
Operating income (loss) 3,235,709 (1,965,802)
Interest expense (109,274) (255,822)
Change in fair value of warrant liability 667,343
Other income, net 8,888 24,749
Net income (loss) before income taxes 3,802,666 (2,196,875)
Income tax expense (330,186)
Net income (loss) 3,472,480 (2,196,875)
Equity dividend to investor (1,488,472)
Net income (loss) attributable to Common Stockholders and holders of Participating Securities 1,984,008 (2,196,875)
Allocation of undistributed earnings to Participating Securities (728,299) 0
Net income (loss) attributable to Common Stockholders $ 1,255,709 $ (2,196,875)
Net income (loss) per share - basic $ 1.39 $ (11.80)
Net income (loss) per share - diluted $ 1.39 $ (11.80)
Weighted average common shares outstanding - basic 904,312 186,149
Weighted average common shares outstanding - diluted 904,312 186,149